文献速递牙周病

非甾体抗炎药与骨关节炎成人牙周炎风险:目标试验模拟

Nonsteroidal Anti-Inflammatory Drugs and the Risk of Periodontitis Among Adults With Osteoarthritis: A Target Trial Emulation.
PubMed 文献 · J Clin Periodontol · 2026-05-23

该研究利用美国电子健康记录(1995-2019)模拟目标试验,比较骨关节炎成人起始使用非甾体抗炎药(NSAIDs)与对乙酰氨基酚的5年牙周炎发病风险。结果显示5年风险差为0.13%(95%CI:-0.32%,0.58%),按COX选择性亚组分析结果相似,未发现NSAIDs影响牙周炎风险的证据。

要点

  • 起始NSAIDs与对乙酰氨基酚相比,5年牙周炎风险差为0.13%(95%CI:-0.32%,0.58%)。
  • 非选择性NSAIDs和优先COX-2 NSAIDs亚组的5年风险差分别为0.11%和0.10%。
  • 负对照结局龋齿的5年风险差为-0.27%(95%CI:-1.01%,0.50%)。

核心结论

  • 未发现起始NSAIDs相较于对乙酰氨基酚影响5年牙周炎风险的证据,且按COX选择性无差异。

研究设计与样本

  • 利用美国电子健康记录(1995-2019)模拟目标试验,纳入骨关节炎成人,比较起始NSAIDs与对乙酰氨基酚者。
  • 采用 pooled logistic 回归模型,并通过逆概率加权调整混杂。

主要发现

  • 5年牙周炎风险差(NSAIDs减对乙酰氨基酚)为0.13%(95%CI:-0.32%,0.58%)。
  • 非选择性NSAIDs亚组5年风险差为0.11%(95%CI:-0.36%,0.59%)。
  • 优先COX-2 NSAIDs亚组5年风险差为0.10%(95%CI:-0.71%,0.92%)。
  • 负对照结局龋齿的5年风险差为-0.27%(95%CI:-1.01%,0.50%)。

临床怎么用

  • 对于骨关节炎成人,起始NSAIDs未显示增加或降低5年牙周炎风险,临床决策无需因牙周炎风险而特别调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) may mitigate periodontal tissue breakdown through cyclooxygenase (COX) inhibition; however, their long-term effects on the risk of periodontitis remain unclear. METHODS: We emulated target trials using US electronic health records (1995-2019) to compare the 5-year risk of incident periodontitis among adults with osteoarthritis-initiating NSAIDs versus acetaminophen. Eligible individuals had osteoarthritis, no prior periodontitis and no recent use of either medication. We estimated the risk of periodontitis using a pooled logistic regression model, adjusting for confounding via inverse probability weighting. Additionally, we conducted a subgroup analysis by NSAID COX selectivity, along with a negative control outcome analysis examining dental caries. RESULTS: The 5-year risk difference (NSAIDs - acetaminophen) was 0.13% (95% CI: -0.32%, 0.58%). Similar findings were observed across subgroups compared with acetaminophen: non-selective NSAIDs, 0.11% (95% CI: -0.36%, 0.59%); preferential COX-2 NSAIDs, 0.10% (95% CI: -0.71%, 0.92%). The 5-year risk difference for dental caries was -0.27% (95% CI: -1.01%, 0.50%). CONCLUSION: We found no evidence that initiating NSAIDs, compared with acetaminophen, influenced the 5-year risk of periodontitis, and no differences by COX selectivity. Our findings align with inconclusive evidence from smaller studies on NSAIDs as adjuncts in periodontitis treatment.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Leiva-Escobar I, Chennas AP, Alayash Z, et al. Nonsteroidal Anti-Inflammatory Drugs and the Risk of Periodontitis Among Adults With Osteoarthritis: A Target Trial Emulation. J Clin Periodontol. 2026. PMID: 42175665. doi:10.1111/jcpe.70145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。